Imugene's market cap is currently $79.95M. The company's EPS TTM is $-0.06242305; its P/E ratio is ―; Imugene is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
